{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:51:10Z","timestamp":1776941470812,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.labinv.2024.102059","type":"journal-article","created":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T21:50:41Z","timestamp":1712958641000},"page":"102059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["N6-Methyladenosine\u2013Modified KREMEN2 Promotes Tumorigenesis and Malignant Progression of High-Grade Serous Ovarian Cancer"],"prefix":"10.1016","volume":"104","author":[{"given":"Rui","family":"Hou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiyao","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5941-1523","authenticated-orcid":false,"given":"Luo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.labinv.2024.102059_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S1470-2045(12)70052-9","article-title":"Ovarian cancer: breaking the silence","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"issue":"Suppl 10","key":"10.1016\/j.labinv.2024.102059_bib2","doi-asserted-by":"crossref","first-page":"x16","DOI":"10.1093\/annonc\/mdt463","article-title":"Origin and molecular pathogenesis of ovarian high-grade serous carcinoma","volume":"24","author":"Kurman","year":"2013","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.labinv.2024.102059_bib3","first-page":"297","article-title":"Epithelial ovarian cancer: prevention, diagnosis, and treatment","volume":"49","author":"Partridge","year":"1999","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.labinv.2024.102059_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00428-012-1203-5","article-title":"Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features","volume":"460","author":"Prat","year":"2012","journal-title":"Virchows Arch"},{"issue":"11","key":"10.1016\/j.labinv.2024.102059_bib5","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","article-title":"Dynamic landscape and evolution of m6A methylation in human","volume":"48","author":"Zhang","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.labinv.2024.102059_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fbioe.2018.00089","article-title":"Link between m6A modification and cancers","volume":"6","author":"Liu","year":"2018","journal-title":"Front Bioeng Biotechnol"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1186\/s12935-021-02318-8","article-title":"RNA m6A methylation regulators in ovarian cancer","volume":"21","author":"Guo","year":"2021","journal-title":"Cancer Cell Int"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib9","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1080\/21655979.2021.1946305","article-title":"m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer","volume":"12","author":"Zhang","year":"2021","journal-title":"Bioengineered"},{"issue":"16","key":"10.1016\/j.labinv.2024.102059_bib10","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-19-4044","article-title":"FTO-dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling","volume":"80","author":"Huang","year":"2020","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.gendis.2021.01.005","article-title":"Critical roles of FTO-mediated mRNA m6A demethylation in regulating adipogenesis and lipid metabolism: implications in lipid metabolic disorders","volume":"9","author":"Yang","year":"2021","journal-title":"Genes Dis"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib12","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13578-022-00798-3","article-title":"m6A demethylase FTO promotes tumor progression via regulation of lipid metabolism in esophageal cancer","volume":"12","author":"Duan","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.labinv.2024.102059_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.857765","article-title":"FTO prevents thyroid cancer progression by SLC7A11 m6A methylation in a ferroptosis-dependent manner","volume":"13","author":"Ji","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.labinv.2024.102059_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/s41420-019-0175-5","article-title":"Kremen1-induced cell death is regulated by homo- and heterodimerization","volume":"5","author":"Sumia","year":"2019","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.labinv.2024.102059_bib15","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.tranon.2018.04.013","article-title":"DKK1 and Kremen expression predicts the osteoblastic response to bone metastasis","volume":"11","author":"Clines","year":"2018","journal-title":"Transl Oncol"},{"key":"10.1016\/j.labinv.2024.102059_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.534095","article-title":"Knockdown of Kremen2 inhibits tumor growth and migration in gastric cancer","volume":"10","author":"Chen","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib17","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13046-023-02692-3","article-title":"Kremen2 drives the progression of non-small cell lung cancer by preventing SOCS3-mediated degradation of EGFR","volume":"42","author":"Sun","year":"2023","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.labinv.2024.102059_bib18","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.labinv.2024.102059_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In\u00a0vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"Mitra","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.labinv.2024.102059_bib20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ejca.2016.08.007","article-title":"Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells","volume":"67","author":"Huang","year":"2016","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.labinv.2024.102059_bib21","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ijc.24271","article-title":"Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis","volume":"125","author":"Onori","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/j.labinv.2024.102059_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/neuonc\/nox165","article-title":"Loss of host-derived osteopontin creates a glioblastoma-promoting microenvironment","volume":"20","author":"Szulzewsky","year":"2018","journal-title":"Neuro Oncol"},{"issue":"7","key":"10.1016\/j.labinv.2024.102059_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/15548627.2019.1659617","article-title":"m(6)A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7","volume":"16","author":"Wang","year":"2020","journal-title":"Autophagy"},{"issue":"7","key":"10.1016\/j.labinv.2024.102059_bib24","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.3390\/ijms23073800","article-title":"FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms","volume":"23","author":"Azzam","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-022-00298-7","article-title":"Role of m6A writers, erasers and readers in cancer","volume":"11","author":"Fang","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.labinv.2024.102059_bib26","article-title":"Comprehensive analysis of the transcriptome-wide m6A methylome in endometrioid ovarian cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.labinv.2024.102059_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.794801","article-title":"Characterization of m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration in ovarian cancer","volume":"9","author":"Luo","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.labinv.2024.102059_bib28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1535-7163.MCT-22-0278","article-title":"N6-methyladenosine RNA modifications regulate the response to platinum through nicotinamide N-methyltransferase","volume":"22","author":"Huang","year":"2023","journal-title":"Mol Cancer Ther"},{"issue":"23","key":"10.1016\/j.labinv.2024.102059_bib29","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2217\/epi-2022-0403","article-title":"N6-methyladenosine methylation regulator FTO promotes oxidative stress and induces cell apoptosis in ovarian cancer","volume":"14","author":"Wu","year":"2022","journal-title":"Epigenomics"},{"issue":"11","key":"10.1016\/j.labinv.2024.102059_bib30","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.1111\/jcmm.15228","article-title":"RNA demethylase ALKBH5 promotes ovarian carcinogenesis in a simulated tumour microenvironment through stimulating NF-kappaB pathway","volume":"24","author":"Jiang","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ccell.2020.04.017","article-title":"Targeting FTO suppresses cancer stem cell maintenance and immune evasion","volume":"38","author":"Su","year":"2020","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib32","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13046-020-01731-7","article-title":"microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKalpha2-FTO-m6A\/MYC axis","volume":"39","author":"Yue","year":"2020","journal-title":"J\u00a0Exp Clin Cancer Res"},{"issue":"33","key":"10.1016\/j.labinv.2024.102059_bib33","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1038\/s41388-021-01916-0","article-title":"FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis","volume":"40","author":"Ruan","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib34","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/s41467-022-35643-1","article-title":"Exon junction complex shapes the m(6)A epitranscriptome","volume":"13","author":"Yang","year":"2022","journal-title":"Nat Commun"},{"issue":"21","key":"10.1016\/j.labinv.2024.102059_bib35","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.3390\/cancers14215218","article-title":"FTO inhibits epithelial ovarian cancer progression by destabilising SNAI1 mRNA through IGF2BP2","volume":"14","author":"Sun","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.labinv.2024.102059_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.105646","article-title":"FTO promotes innate immunity by controlling NOD1 expression via m(6)A-YTHDF2 manner in teleost","volume":"25","author":"Geng","year":"2022","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.labinv.2024.102059_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","article-title":"The role of m6A modification in the biological functions and diseases","volume":"6","author":"Jiang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.labinv.2024.102059_bib38","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"6","key":"10.1016\/j.labinv.2024.102059_bib39","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.tcb.2019.02.008","article-title":"Regulation of gene expression by N(6)-methyladenosine in cancer","volume":"29","author":"Liu","year":"2019","journal-title":"Trends Cell Biol"},{"issue":"Part 3","key":"10.1016\/j.labinv.2024.102059_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2022.05.009","article-title":"The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer","volume":"86","author":"Ramesh-Kumar","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"17","key":"10.1016\/j.labinv.2024.102059_bib41","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.3748\/wjg.14.2702","article-title":"Transcriptional silencing of Dickkopf gene family by CpG island hypermethylation in human gastrointestinal cancer","volume":"14","author":"Maehata","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.labinv.2024.102059_bib42","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.critrevonc.2019.05.014","article-title":"Ovarian cancer relapse: from the latest scientific evidence to the best practice","volume":"140","author":"Luvero","year":"2019","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"10.1016\/j.labinv.2024.102059_bib43","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3892\/ijo.2013.2037","article-title":"MicroRNA-29a induces resistance to gemcitabine through the Wnt\/beta-catenin signaling pathway in pancreatic cancer cells","volume":"43","author":"Nagano","year":"2013","journal-title":"Int J Oncol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724017379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683724017379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:58:31Z","timestamp":1762210711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683724017379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0023683724017379"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102059","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N6-Methyladenosine\u2013Modified KREMEN2 Promotes Tumorigenesis and Malignant Progression of High-Grade Serous Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2024.102059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102059"}}